Renovaro Biosciences Inc.
(RENB)
undefined
undefined%
At close: undefined
1.71
-3.39%
After-hours Dec 13, 2024, 06:08 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Cash & Equivalents | 220.47K | 1.87M | 9.17M | 20.66M | 8.70M | 12.28M | 15.60M | 3.94M | 23.37K |
Short-Term Investments | - | - | - | - | - | - | - | - | - |
Long-Term Investments | - | - | - | - | - | - | - | 196.14K | - |
Other Long-Term Assets | 19.85K | 21.74K | 68.64K | 20.98K | 137.55K | 155.05M | 155.07M | 127.13K | 138.35K |
Receivables | 1.11M | - | - | 1.64K | 1.98K | 20.79K | 122.87K | 223.78K | 695.42K |
Inventory | - | - | - | -1.64K | - | - | - | - | - |
Other Current Assets | 668.93K | 690.92K | 393.00K | 232.94K | 244.85K | 191.97K | 38.28K | 33.39K | 13.69K |
Total Current Assets | 2.00M | 2.57M | 9.57M | 20.90M | 8.94M | 12.49M | 15.76M | 4.20M | 732.48K |
Property-Plant & Equipment | 1.75M | 1.42M | 1.74M | 2.16M | 2.48M | 687.52K | 27.40K | - | - |
Goodwill & Intangibles | 159.36M | 54.29M | 73.26M | 166.53M | 166.54M | 11.64M | 11.64M | - | - |
Total Long-Term Assets | 161.13M | 55.74M | 75.07M | 168.71M | 169.16M | 167.38M | 166.74M | 323.27K | 138.35K |
Total Assets | 163.13M | 58.30M | 84.63M | 189.61M | 178.10M | 179.88M | 182.50M | 4.52M | 870.83K |
Account Payables | 9.45M | 5.30M | 1.40M | 320.56K | 592.88K | 538.56K | 806.81K | 434.97K | 1.19M |
Deferred Revenue | 231.38K | 723.17K | 1.03M | 1.18M | - | - | - | 1.00 | - |
Short-Term Debt | 2.94M | 5.00M | 1.45M | 292.41K | 271.29K | - | - | 2.09M | 102.88K |
Other Current Liabilities | 17.92M | 723.17K | 3.60M | 1.27M | 470.64K | 571.85K | 66.91K | 464.60K | 220.23K |
Total Current Liabilities | 30.31M | 11.02M | 6.45M | 1.89M | 1.33M | 1.11M | 873.72K | 2.99M | 1.51M |
Long-Term Debt | 842.39K | 775.59K | 5.56M | 7.02M | 7.31M | - | - | - | - |
Other Long-Term Liabilities | - | - | - | 6.04M | 3.18M | 5.67M | 22.89M | - | - |
Total Long-Term Liabilities | 842.39K | 775.59K | 5.56M | 13.06M | 10.49M | 5.67M | 22.89M | - | - |
Total Liabilities | 31.15M | 11.80M | 12.01M | 14.94M | 11.83M | 6.78M | 23.76M | 2.99M | 1.51M |
Total Debt | 3.79M | 5.59M | 7.02M | 7.31M | 7.58M | - | - | 2.09M | 102.88K |
Common Stock | 15.50K | 6.37K | 5.30K | 5.22K | 4.65K | 4.53K | 3.62K | 1.24K | 953.00 |
Retained Earnings | -324.68M | -244.03M | -204.35M | -90.91M | -64.19M | -52.77M | -34.76M | -28.44M | -26.30M |
Comprehensive Income | -170.85K | -29.88K | -30.44K | -10.83K | -41.42K | 101.82K | 205.68K | 352.83K | 564.29K |
Shareholders Equity | 131.98M | 46.50M | 72.62M | 174.66M | 166.27M | 173.10M | 158.74M | 1.53M | -637.40K |
Total Investments | - | - | - | - | - | - | - | 196.14K | - |